Chinook Therapeutics has raised US$65 million in Series A financing. Versant Ventures led the round with participation from Apple Tree Partners and Samsara BioCapital. Based in Seattle and Vancouver, British Columbia, Chinook is a developer of precision medicines for kidney diseases.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.